Andere talen AptarGroup, Inc.

Aandelen

ATR

US0383361039

Beurs gesloten - Nyse Andere beurzen 22:00:02 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
140,2 ^USD	+0,12%		+0,77%	+13,40%

25/04	AptarGroup aangepaste winst over Q1, omzet stijgt; stelt EPS-richtlijn voor Q2 vast	MT
25/04	AptarGroup, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

AptarGroup Q1 Adjusted Earnings, Sales Rise; Sets Q2 EPS Guidance	25/04
AptarGroup : Q1 Press Release Presentation	25/04
AptarGroup, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
AptarGroup: Q1 Earnings Snapshot	25/04
Earnings Flash (ATR) APTARGROUP Posts Q1 Revenue $915.4M, vs. Street Est of $890.9M	25/04
Earnings Flash (ATR) APTARGROUP Reports Q1 EPS $1.26, vs. Street Est of $1.15	25/04
Aptar Reports First Quarter 2024 Results	25/04
AptarGroup Keeps Quarterly Cash Dividend at $0.41 a Share, Payable May 16 to Holders of Record April 25	11/04
Aptar Declares Quarterly Dividend	11/04
AptarGroup, Inc. Declares Quarterly Dividend, Payable on May 16, 2024	11/04
Aptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive Year	20/03
Aptar - Food Protection Enters Exclusive Partnership with Halopack to Launch Recyclable, Fiber-based Tray System in North America	15/03
Aptargroup Insider Sold Shares Worth $284,906, According to a Recent SEC Filing	12/03
Aptargroup Insider Sold Shares Worth $499,932, According to a Recent SEC Filing	12/03
Aptargroup Insider Sold Shares Worth $4,533,394, According to a Recent SEC Filing	05/03
Aptar Named One of Barron's 100 Most Sustainable U.S. Companies for the Sixth Consecutive Year	01/03
Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Sixth Consecutive Year	29/02
Tanda, CEO of Aptar: Inflation less of a concern in the pharmaceutical sector	12/02
Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions	12/02
AptarGroup's Digital Health Business, Biogen to Develop Products for Neurological, Rare Diseases	09/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen AptarGroup, Inc.

Aandelen

ATR

US0383361039

Andere talen

Filters